New Age Farm and NHS Industries Ltd. Announce the Filing of Preliminary         Non-Offering Prospectus by NHS

May 16, 2017 – Vancouver, BC

New Age Farm Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (www.newagefarminc.com) (“New Age Farm” or the “Company”) announces that its subsidiary, NHS Industries Ltd. (“NHS”)  has filed and obtained a receipt for its preliminary non-offering prospectus with the British Columbia Securities Commission (the “BCSC”).  The preliminary prospectus contains important information relating to NHS and its currently issued securities and is subject to amendment as may be required by the BCSC.  Copies of the preliminary prospectus are available on SEDAR at http://www.sedar.com under NHS’ SEDAR profile.  NHS is the subject of a plan of arrangement with the Company whereby NHS will spin out from the Company to become an independently operated company and reporting issuer that will list its common shares on the Canadian Securities Exchange (the “CSE”).  The preliminary prospectus is the first step in this listing process.  NHS will now submit its listing application to the CSE and has reserved the trading symbol “NHS” for its common shares.  More information regarding the Company and the plan of arrangement with NHS can be found in the Company’s disclosure record on SEDAR.

NHS is an agricultural services company based in Langley, BC focused on providing turnkey agricultural services at its fully Agricultural Land Reserve-approved location to entry level agricultural businesses seeking a location where they can take their product from seed to sale.  NHS will offer value added services to offsite growers who wish to increase potential revenues from small scale agricultural operations.  There is a significant trend toward local, clean-label food and NHS is positioned to assist growers in achieving maximum potential from their crops whether grown on the Langley site or grown off-site and brought in for further processing, storage and distribution.  The entry barriers to becoming a grower are high. NHS aims to minimize the initial start-up costs for new growers by providing turnkey solutions that allow a tenant grower on its site to arrive, flip a switch and start farming.  For growers who may have a small scale agricultural operation off-site, there are infrastructure, personnel and regulatory costs associated with creating a value added product from their crops.  In a business with high overhead and tight margins, there may not be cash available to build on this infrastructure to get this aspect of their business underway.  By providing everything the small-scale operator needs under one umbrella, NHS can help them increase the value of the crops by turning them into marketable products thereby allowing the operator to get the maximum income from its operations.

Update to Plan of Arrangement

The filing of the preliminary prospectus is the first step in qualifying the NHS Shares for trading on a stock exchange.  Once the BCSC has reviewed the preliminary prospectus and provided their commentary, NHS will respond and update the prospectus until such time as the BCSC accepts it as final.  This process will take several weeks, after which time the NHS Shares will be ready to be listed for trading on the CSE.  Until such time, New Age Farm continues to hold the NHS Shares in trust for the New Age Farm shareholders who are qualified to receive NHS Shares as of the Share Distribution Record Date (see New Age Farm news releases dated September 22, November 10 and December 5, 2016).  The Company has prepared a series of FAQ’s for shareholders who are seeking more information on the Plan of Arrangement and the distribution of the NHS Shares, which can be found on its website at http://newagefarminc.com/investors/nhs-faqs/ .

Carman Parente, president and CEO of New Age Farm commented, “The Company understands that shareholders are eager to receive their NHS Shares, and we are undertaking all steps required to have the NHS Shares issued to shareholders in as timely manner as possible, while taking into account that until NHS is listed on a stock exchange, there is no market for the shares.  Therefore, the Company and NHS are working toward the listing event as a very significant milestone and a high priority so that we can bring this new value to shareholders.  We look forward to working with the CSE to list the NHS Shares on the exchange.”

For further information about New Age Farm, please consult the Company’s profile on SEDAR at www.sedar.com.

###

WWW.NEWAGEFARMINC.COM

Follow us

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, but not limited to completion of planned improvements at both the Canadian and US sites on schedule and on budget, the availability of  financing needed  to complete the Company’s planned improvements on commercially reasonable terms, the availability of contractors and materials, planned occupancy by the tenant-growers, commencement of operations, weather and other natural factors that may affect agriculture based businesses, the ability to mitigate the risk of loss through appropriate insurance policies, and the risks presented by federal statutes that may contradict local and state legislation respecting legalized marijuana. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. 

This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon. 

Disclaimer

© 2010 Junior Gold Report and TechMoney360

Junior Gold Report and TechMoney360 Newsletter: Junior Gold Report’s and Tech Money 360’s Newsletter is published as a copyright publication of Junior Gold Report (JGR) and TechMoney360 (TM360).  No Guarantee as to Content:  Although JGR/TM360 attempts to research thoroughly and present information based on sources we believe to be reliable, there are no guarantees as to the accuracy or completeness of the information contained herein. Any statements expressed are subject to change without notice. It may contain errors and you should not make any investment decisions based on what you have read on here. JGR/TM360, its associates, authors, and affiliates are not responsible for errors or omissions. By accessing the site and receiving this email, you accept and agree to be bound by and comply with the terms and conditions as set out herein. If you do not accept and agree to the terms you should not use the Junior Gold Report and TechMoney360 sites or accept this email. Consideration for Services: JGR/TM360, it’s editor, affiliates, associates, partners, family members, or contractors may have an interest or position in the featured companies, as well as sponsored companies which compensate JGR/TM360 as such our opinions are biased. We may hold potions in and trade these stocks of the companies we profile and as such our opinions are biased. JGR/TM360 and its’ owner and affiliates/associates may buy/sell and trade the featured companies from time to time. JGR/TM360 has been paid by the companies. Thus, multiple conflicts of interest exist. Therefore, information provided here within should not be construed as a financial analysis but rather as an advertisement. Conduct your own due diligence: The author’s views and opinions regarding the companies featured in report(s) are his/her own views and are based on information that he/she has researched independently and has received, which the author assumes to be reliable. You should never base any buying/selling/trading decisions off of our emails, newsletter, website, videos or any of our published materials. JGR/TM360 aims to provide information and often stock ideas but are by no means recommendations. The ideas and companies featured are highly speculative and you could lose your entire investment – consult a licensed financial advisor if you are considering investing in any of the featured companies. Subscribers/readers are encouraged to conduct their own research and due diligence. The companies mentioned are high risk and considered penny stocks that contain a high risk of volatility, therefore consult your investment advisor and do your own due diligence before purchasing. Never base any investment decision on information contained from our emails, newsletter, website, videos or any of our published materials. No Offer to Sell Securities: JGR/TM360 is not a registered broker dealer, investment advisor, financial analyst, stock picker, investment banker or other investment professional. JGR/TM360 is intended for informational, educational and research purposes only. It is not to be considered as investment advice. No statement or expression of any opinions contained in this report constitutes an offer to buy or sell the shares of the companies mentioned herein. Links: JGR/TM360 may contain links to related websites for stock quotes, charts, etc. JGR/TM360 is not responsible for the content of or the privacy practices of these sites. Information contained herein was extracted from public filings, profiled company websites, and other publicly available sources deemed reliable. Information in this report was taken on or before writing and dissemination and may not be updated. Do you own due diligence as information and events can and do change. Published reports may reference company websites or link to company websites and we disclaim and responsibility for the content and accuracy of any such information or website. Release of Liability: By reading and/or watching videos by JGR/TM360, you agree to hold JGR/TM360, its associates, sponsors, affiliates, and partners harmless and to completely release them from any and all liabilities due to any and all losses, damages, or injuries (financial or otherwise) that may be incurred.

Forward Looking Statements
Except for statements of historical fact, certain information contained herein constitutes forward-looking statements. Forward looking statements are usually identified by the use of certain terminology, including “will”, “believes”, “may”, “expects”, “should”, “seeks”, “anticipates”, “has potential to”, or “intends’ or by discussions of strategy, forward looking numbers or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts, and include but are not limited to, estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to the effectiveness of the Company’s business model; future operations, products and services; the impact of regulatory initiatives on the Company’s operations; the size of and opportunities related to the market for the Company’s products; general industry and macroeconomic growth rates; expectations related to possible joint and/or strategic ventures and statements regarding future performance. Junior Gold Report/TechMoney360 does not take responsibility for the accuracy of forward looking statements and advises the reader to perform their own due diligence on forward looking numbers or statements.